Literature DB >> 18843511

Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions.

Kari Hemminki1, Xinjun Li, Jan Sundquist, Jan Hillert, Kristina Sundquist.   

Abstract

In the era of complex disease genetics, the consideration of familial risks is important in the assessment of the likely success of these studies. In the present article, we study familial risks for multiple sclerosis (MS) among parents and offspring, singleton siblings, twins, and spouses when a family member was diagnosed with MS or any of 33 other autoimmune diseases. The availability of a Multigeneration Register in Sweden provides a reliable access to families throughout the last century. The diseases in individual family members were obtained through linkage to the Hospital Discharge Register. With a total patient population of 425,102 of whom 11,154 were diagnosed with MS, this is the largest population-based family study on these diseases to date. Standardized incidence ratio (SIR) was calculated for family member of MS patients compared to those lacking an affected family member. SIR for MS was 5.94 (6.12 when parents were aged <73 years) in offspring of affected parents, 6.25 in singleton siblings, 9.09 in twins, and 1.50 (nonsignificant) in spouses; the SIRs did not depend on the gender. The SIRs for MS were 1.84 when a parent was diagnosed with amyotrophic lateral sclerosis and 1.14 with parental asthma. The overall risk of MS was 1.21 when a parent was diagnosed with any autoimmune disease. The genes, so far associated with MS, explain little of the familial aggregation of MS, calling for further efforts in gene identification. The shared familial risks of MS with amyotrophic lateral sclerosis and asthma suggest shared genetic basis.

Entities:  

Mesh:

Year:  2008        PMID: 18843511     DOI: 10.1007/s10048-008-0156-y

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  25 in total

1.  Further considerations on the distribution of multiple sclerosis in Sweden.

Authors:  A-M Landtblom; T Riise; J F Kurtzke
Journal:  Acta Neurol Scand       Date:  2005-04       Impact factor: 3.209

Review 2.  Neuromyelitis optica: a distinct demyelinating disease of the central nervous system.

Authors:  A A Argyriou; N Makris
Journal:  Acta Neurol Scand       Date:  2008-03-11       Impact factor: 3.209

Review 3.  Familial risks for common diseases: etiologic clues and guidance to gene identification.

Authors:  Kari Hemminki; Xinjun Li; Kristina Sundquist; Jan Sundquist
Journal:  Mutat Res       Date:  2008-01-12       Impact factor: 2.433

Review 4.  The genetics of multiple sclerosis and its experimental models.

Authors:  Tomas Olsson; Jan Hillert
Journal:  Curr Opin Neurol       Date:  2008-06       Impact factor: 5.710

Review 5.  Familial multiple sclerosis and other inherited disorders of the white matter.

Authors:  Bernadette Kalman; Thomas P Leist
Journal:  Neurologist       Date:  2004-07       Impact factor: 1.398

6.  Autoimmune disease in families with multiple sclerosis: a population-based study.

Authors:  Sreeram Varadharajan Ramagopalan; David Alexandre Dyment; William Valdar; Blanca Marcela Herrera; Maria Criscuoli; Irene Mei Ling Yee; Adele Dessa Sadovnick; George Cornell Ebers
Journal:  Lancet Neurol       Date:  2007-07       Impact factor: 44.182

7.  Familial risks of cancer as a guide to gene identification and mode of inheritance.

Authors:  Kari Hemminki; Xinjun Li
Journal:  Int J Cancer       Date:  2004-06-10       Impact factor: 7.396

Review 8.  Genetics of multiple sclerosis.

Authors:  David A Dyment; George C Ebers; A Dessa Sadovnick
Journal:  Lancet Neurol       Date:  2004-02       Impact factor: 44.182

9.  Sibling risks in cancer: clues to recessive or X-linked genes?

Authors:  K Hemminki; P Vaittinen; C Dong; D Easton
Journal:  Br J Cancer       Date:  2001-02-02       Impact factor: 7.640

10.  The 'common disease-common variant' hypothesis and familial risks.

Authors:  Kari Hemminki; Asta Försti; Justo Lorenzo Bermejo
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

View more
  21 in total

Review 1.  Multiple sclerosis genetics--is the glass half full, or half empty?

Authors:  Jorge R Oksenberg; Sergio E Baranzini
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

2.  Familial risks for amyotrophic lateral sclerosis and autoimmune diseases.

Authors:  Kari Hemminki; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Neurogenetics       Date:  2008-12-17       Impact factor: 2.660

3.  Inflammation in the spotlight-clinical relevance of genetic variants affecting nuclear factor κB and tumor necrosis factor receptor 1.

Authors:  Francisco J Ortega; José M Fernández-Real
Journal:  Ann Transl Med       Date:  2017-05

4.  Annotation of functional variation within non-MHC MS susceptibility loci through bioinformatics analysis.

Authors:  F B S Briggs; L J Leung; L F Barcellos
Journal:  Genes Immun       Date:  2014-07-17       Impact factor: 2.676

Review 5.  Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview.

Authors:  Meysam Moghbeli
Journal:  Cell Mol Neurobiol       Date:  2019-09-03       Impact factor: 5.046

6.  Familial risk of inflammatory bowel disease: a population-based cohort study 1977-2011.

Authors:  Frederik Trier Moller; Vibeke Andersen; Jan Wohlfahrt; Tine Jess
Journal:  Am J Gastroenterol       Date:  2015-03-24       Impact factor: 10.864

7.  A single nucleotide polymorphism in Tyk2 controls susceptibility to experimental allergic encephalomyelitis.

Authors:  Karen M Spach; Rajkumar Noubade; Ben McElvany; William F Hickey; Elizabeth P Blankenhorn; Cory Teuscher
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

8.  Familial association between type 1 diabetes and other autoimmune and related diseases.

Authors:  K Hemminki; X Li; J Sundquist; K Sundquist
Journal:  Diabetologia       Date:  2009-06-20       Impact factor: 10.122

9.  Major histocompatibility complex class I and class II alleles may confer susceptibility to or protection against morphea: findings from the Morphea in Adults and Children cohort.

Authors:  Heidi Jacobe; Chul Ahn; Frank C Arnett; John D Reveille
Journal:  Arthritis Rheumatol       Date:  2014-11       Impact factor: 10.995

10.  What role for genetics in the prediction of multiple sclerosis?

Authors:  Stephen Sawcer; Maria Ban; James Wason; Frank Dudbridge
Journal:  Ann Neurol       Date:  2010-01       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.